Winner of the
2008 Minnesota Cup
The first device from CoreSpine Technologies is intended to safely and effectively provide a complete nucleus removal through improved access, especially via the posterior approach. It is intended to protect the annulus and endplates from further damage during the process of preparing the disc space for a spinal implant. Ultimately, the XTEND-ST Nucleus Removal System seeks to enable emerging devices to be properly positioned within a well-prepared disc space. The XTEND-ST™ system is fully automated and requires no capital equipment expenditure.
The technology has also been licensed for use outside the spine.
Download Clinical Information:
Future Products
XTEND-CR™ System
As CoreSpine expands its platform technology, the XTEND-CR Cartilage Removal System will be the next device the company will seek to commercialize. Innovative engineering work has already begun to develop and refine the best design to remove only the cartilaginous endplate. Similar to the XTEND-ST device, this product will seek to remove only the cartilagenous endplate and not surrounding tissues, including annulus and bone.
Upon commercialization of the XTEND-CR device, CoreSpine will support additional product development efforts that serve unmet needs within the spine industry.
The XTEND-CR device is not yet cleared by the FDA for sale in the US.